Icure Pharmaceutical Inc

175250

Company Profile

  • Business description

    Icure Pharmaceutical Inc operates as a biopharmaceutical company engages in the development and commercialization of novel transdermal drug delivery formulation. It also developed and commercialized various patches and hydrogels for the treatment of rheumatic arthritis pain, nicotine replacement therapy, medicated wound dressings, skin care, and dental care. The products pipeline is also aimed at the development of prescription drugs to diseases of the central nervous system, asthma, and pain.

  • Contact

    7, Saimdang-ro 1-gil
    Seocho-gu
    Seoul
    KOR

    T: +82 269596909

    https://www.icure.co.kr

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    293

Stocks News & Analysis

stocks

Is this ASX share a long-term buy?

Current operating conditions are challenging but over the long-term prospects are better.
stocks

Why Guzman and Reece's share reversals have a lot in common

Investors must weigh exciting growth stories against competitive dynamics and the price they are being asked to pay.
stocks

Going into earnings, is Nvidia stock a buy, a sell, or fairly valued?

Watching the data centre business and the debate around it, here’s what we think of Nvidia stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,477.3020.70-0.24%
CAC 408,137.2686.191.07%
DAX 4022,732.24321.971.44%
Dow JONES (US)43,758.96137.800.32%
FTSE 1008,722.0353.360.62%
HKSE23,787.93753.913.27%
NASDAQ19,196.80170.410.90%
Nikkei 22538,142.3795.42-0.25%
NZX 50 Index12,452.46145.191.18%
S&P 5005,991.4536.200.61%
S&P/ASX 2008,240.7011.20-0.14%
SSE Composite Index3,380.2134.171.02%

Market Movers